CTRI/2020/11/029232尚未招募3 期
Efficacy Of Montelukast In the Management Of COVID 19 - A Double Blind Randomized Placebo Controlled Trial - EMMC
I0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients above the age of 14 years both males and females, admitted with a
- •diagnosis of mild or moderate COVID -19 (on the basis of a positive RT-PCR report) at our facility
- •during the study period (01/09/2020-31/12/2020)
排除标准
- •1. Patients with a known allergy to or adverse drug reaction with Montelukast.
- •2. Patients unable to provide consent or unwilling to participate in the study.
- •3. Patients included in any other ongoing trial will be excluded from the study.
- •4. Patients below the age of 14 years will be excluded from the study.
- •5. Pregnant and Lactating Females will be excluded from the study.
研究者
相似试验
已完成
3 期
Therapeutic effect of Montelukast in patients with oral lichen planusLichen Planusichen Planus.IRCT2012110811389N2Vice Chancellor for Research , Hamedan University of Medical Sciences200
尚未招募
3 期
The effect of Montelukast in the treatment of cystitisCystitisCystitis.IRCT20220203053919N1Arak University of Medical Sciences56
进行中（未招募）
1 期
Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19)EUCTR2020-001747-21-PTInstituto de Saúde Pública Universidade Porto160
已完成
3 期
Evaluation of montelukast efficacy on clinical and FEV1/PEFR improvement in acute basthma attackAcute attack asthma.AsthmaIRCT2015092215446N5Vice chanceller for research, Ahvaz Jundishapur University of Medical Sciences80
招募中
2 期
Comparison of the effects of Oral Montelukast with Oral Zileuton in sudden attack of asthma.CTRI/2013/12/004260Dr Shahul Hameed Aboobackar120